510(k) Report

510(k) · Cleared

Cleared

Liquichek Ana Control, Speckled Pattern, Positive, Catalog #108

K024217510(k) TraditionalCleared Jan 15, 200323-day reviewClass II21 CFR 866.5100

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Bio-Rad · DHN Antinuclear Antibody, Indirect Immunofluorescent, Antigen, Control

Cleared on Jan 15, 2003 as substantially equivalent to K792610 (Kallestad Laboratories, Inc., 1980) after a 23-day review. Its family tree reaches back 1 generation to 1980.

Decided
Jan 15, 2003
Review
23 days
Class
Class II
Product code
DHN
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to K792610 (1980). No later device cites it as a predicate yet.

K792610 · Kallestad Florescent Ana/Ama/Asma Test · Kallestad Laboratories, Inc. · 1980 · recalled198019851990199520002005
  1. Root · 1 generation backK792610 Kallestad Florescent Ana/Ama/Asma TestKallestad Laboratories, Inc. · 1980 · Recalled
  2. This deviceK024217 Liquichek Ana Control, Speckled Pattern, Positive, Catalog #108Bio-Rad · 2003
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K792610Kallestad Florescent Ana/Ama/Asma TestKallestad Laboratories, Inc.19801
0 (this device)K024217Liquichek Ana Control, Speckled Pattern, Positive, Catalog #108Bio-Rad2003—
FIG. 1 — Lineage of K024217, 1980–2003Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in DHN? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K792610Kallestad Florescent Ana/Ama/Asma Test
Summary page 1
…3.0 Device to Which Substantial Equivalence is Claimed KallestadTMAutoantibody Positive Control Bio-Rad Laboratories 510 (k) Number: K792610 4.0 Description of Device This product is prepared from human serum with added preservatives. The co…
Kallestad Laboratories, Inc.19801

Also cleared against K792610: 6 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has a recall.
  • 6 other devices also cite its predicate K792610.

How does its category compare?

All DHN devices

DHN Antinuclear Antibody, Indirect Immunofluorescent, Antigen, Control: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · DHN

1in 2022

2007: 12012: 12014: 12015: 22016: 22018: 12022: 1
2007high 2 (2015) · low 0 (2008)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · DHN

Too few DHN 510(k)s in any year since 2007 to give a median.

Recalls per year · DHN

1in 2011

2008: 22010: 12011: 1
2007high 2 (2008) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · DHN

No MAUDE report names DHN since 2007.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—00
20080—20
20090—00
20100—10
20110—10
20121—00
20130—00
20141—00
20152—00
20162—00
20170—00
20181—00
20190—00
20200—00
20210—00
20221—00
20230—00
20240—00
20250—00
20260—0—

What is it indicated for?

The LiquichekTMANA Control, Speckled Pattern, Positive, is intended for use as an unassayed quality control to monitor indirect immunofluorescent testing of antinuclear antibodies (ANA).

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K024217: Liquichek Ana Control, Speckled Pattern, Positive, Catalog #108.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 3, 2026. https://510kreport.com/device/K024217

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026